Urokinase plasminogen activator receptor levels in Behcet's disease

BİRENGEL M. S., YALÇINDAĞ F. N., Yalcindag A., ŞAHLI E., ŞERMET F.

THROMBOSIS RESEARCH, cilt.128, sa.3, ss.274-276, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 128 Sayı: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.thromres.2011.03.003
  • Dergi Adı: THROMBOSIS RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.274-276
  • Anahtar Kelimeler: uPAR, Behcet's disease, GENE G20210A MUTATIONS, FACTOR-V-LEIDEN, PROTEIN-S DEFICIENCY, VENOUS THROMBOSIS, ANTICARDIOLIPIN ANTIBODIES, FIBRINOLYSIS INHIBITOR, COAGULATION PARAMETERS, THROMBOPHILIC FACTORS, C DEFICIENCY, MANIFESTATIONS
  • Ankara Üniversitesi Adresli: Evet

Özet

Purpose: To determine urokinase plasminogen activator receptor (uPAR) concentrations in Behcet patients with and without ocular involvement; and to investigate the associations between uPAR levels and clinical manifestations of Behcet's disease.